EyePoint Pharmaceuticals (EYPT)
(Delayed Data from NSDQ)
$10.23 USD
+0.16 (1.59%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $10.23 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
EYEPOINT PHARMACEUTICALS, INC.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EYPT 10.23 +0.16(1.59%)
Will EYPT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EYPT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EYPT
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
EYPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
EyePoint Pharmaceuticals (EYPT) Reports Q1 Earnings: What Key Metrics Have to Say
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates
EyePoint Pharmaceuticals (EYPT) Reports Q4 Earnings: What Key Metrics Have to Say
Other News for EYPT
EyePoint Pharmaceuticals (EYPT): Chardan Capital Maintains "Buy" Rating | EYPT Stock News
EyePoint Pharmaceuticals (EYPT) Receives Updated Analyst Ratings | EYPT Stock News
Q2 2025 EyePoint Pharmaceuticals Inc Earnings Call Transcript
EyePoint price target raised by $1 at H.C. Wainwright, here's why
EyePoint to Present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference | EYPT ...